INHALERX LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.04 AUD | +2.56% |
|
0.00% | +37.93% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 4.654 | 2.637 | 10.38 | 15.16 | 11.24 | 5.503 |
| Enterprise Value (EV) 1 | 2.34 | 2.212 | 8.658 | 12.36 | 9.103 | 5.348 |
| P/E ratio | -2.7 x | -1.1 x | -6.34 x | -13.6 x | -5.39 x | -3.81 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 12.3 x | 19.8 x | 469 x | 83.4 x | 453 x | 4.57 x |
| EV / Revenue | 6.2 x | 16.6 x | 391 x | 68 x | 367 x | 4.44 x |
| EV / EBITDA | -1.23 x | -1.22 x | -7.57 x | -11.1 x | -4.68 x | -3.78 x |
| EV / FCF | -1.71 x | -2.01 x | -16.8 x | -12.8 x | -8.4 x | -3.36 x |
| FCF Yield | -58.4% | -49.9% | -5.94% | -7.84% | -11.9% | -29.8% |
| Price to Book | 1.73 x | 7.76 x | 7.84 x | 5.66 x | 5.91 x | 8.27 x |
| Nbr of stocks (in thousands) | 77,569 | 77,569 | 1,34,773 | 1,68,467 | 1,87,267 | 1,89,767 |
| Reference price 2 | 0.0600 | 0.0340 | 0.0770 | 0.0900 | 0.0600 | 0.0290 |
| Announcement Date | 29/03/19 | 31/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 28/03/24 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.3773 | 0.133 | 0.0221 | 0.1817 | 0.0248 | 1.204 |
| EBITDA 1 | -1.895 | -1.814 | -1.144 | -1.11 | -1.944 | -1.414 |
| EBIT 1 | -1.928 | -1.847 | -1.206 | -1.111 | -1.954 | -1.423 |
| Operating Margin | -510.95% | -1,388.74% | -5,448.4% | -611.57% | -7,879.44% | -118.22% |
| Earnings before Tax (EBT) 1 | -1.749 | -2.388 | -1.205 | -1.111 | -1.927 | -1.443 |
| Net income 1 | -1.676 | -2.388 | -1.205 | -1.111 | -1.927 | -1.443 |
| Net margin | -444.13% | -1,795.63% | -5,447.08% | -611.38% | -7,770.36% | -119.87% |
| EPS 2 | -0.0222 | -0.0308 | -0.0122 | -0.006630 | -0.0111 | -0.007621 |
| Free Cash Flow 1 | -1.366 | -1.103 | -0.5143 | -0.9689 | -1.084 | -1.592 |
| FCF margin | -361.97% | -829.73% | -2,324.39% | -533.12% | -4,371.28% | -132.2% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/03/19 | 31/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 28/03/24 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 2.31 | 0.42 | 1.72 | 2.8 | 2.13 | 0.16 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.37 | -1.1 | -0.51 | -0.97 | -1.08 | -1.59 |
| ROE (net income / shareholders' equity) | -47.9% | -158% | -145% | -55.5% | -84.1% | -112% |
| ROA (Net income/ Total Assets) | -29.5% | -62.1% | -59.6% | -28.7% | -47.1% | -46.4% |
| Assets 1 | 5.686 | 3.842 | 2.022 | 3.867 | 4.094 | 3.111 |
| Book Value Per Share 2 | 0.0300 | 0 | 0.0100 | 0.0200 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.0300 | 0.0100 | 0.0100 | 0.0200 | 0.0100 | 0 |
| Capex 1 | 0.09 | 0.04 | - | 0.01 | - | - |
| Capex / Sales | 23.53% | 27.33% | - | 6.34% | - | - |
| Announcement Date | 29/03/19 | 31/03/20 | 31/03/21 | 31/03/22 | 30/03/23 | 28/03/24 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +37.93% | 5.03M | |
| +12.85% | 227B | |
| +13.88% | 192B | |
| +18.39% | 136B | |
| +28.78% | 108B | |
| +1.67% | 64.07B | |
| +18.24% | 52.1B | |
| +7.04% | 51.87B | |
| +10.83% | 44.33B | |
| +5.94% | 36.75B |
- Stock Market
- Equities
- IRX Stock
- Financials InhaleRx Limited
